457 related articles for article (PubMed ID: 26576856)
1. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
[TBL] [Abstract][Full Text] [Related]
2. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.
Schoggins JW; Falck-Pedersen E
J Virol; 2006 Nov; 80(21):10634-44. PubMed ID: 16943295
[TBL] [Abstract][Full Text] [Related]
3. The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Dicks MD; Guzman E; Spencer AJ; Gilbert SC; Charleston B; Hill AV; Cottingham MG
Vaccine; 2015 Feb; 33(9):1121-8. PubMed ID: 25629523
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
[TBL] [Abstract][Full Text] [Related]
5. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.
Tatsis N; Blejer A; Lasaro MO; Hensley SE; Cun A; Tesema L; Li Y; Gao GP; Xiang ZQ; Zhou D; Wilson JM; Ertl HC
Mol Ther; 2007 Mar; 15(3):608-17. PubMed ID: 17228314
[TBL] [Abstract][Full Text] [Related]
6. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
7. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
[TBL] [Abstract][Full Text] [Related]
8. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
[TBL] [Abstract][Full Text] [Related]
10. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
[TBL] [Abstract][Full Text] [Related]
11. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.
Madisch I; Hofmayer S; Moritz C; Grintzalis A; Hainmueller J; Pring-Akerblom P; Heim A
J Virol; 2007 Aug; 81(15):8270-81. PubMed ID: 17522221
[TBL] [Abstract][Full Text] [Related]
12. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase Motif.
Miao W; Roohi Ahangarani R; Carlier V; Vander Elst L; Saint-Remy JM
Hum Gene Ther; 2016 Mar; 27(3):230-43. PubMed ID: 26711172
[TBL] [Abstract][Full Text] [Related]
14. Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5.
Lv Y; Xiao FJ; Wang Y; Zou XH; Wang H; Wang HY; Wang LS; Lu ZZ
BMC Biotechnol; 2019 Apr; 19(1):23. PubMed ID: 31014302
[TBL] [Abstract][Full Text] [Related]
15. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
Bassett JD; Swift SL; Bramson JL
Expert Rev Vaccines; 2011 Sep; 10(9):1307-19. PubMed ID: 21919620
[TBL] [Abstract][Full Text] [Related]
16. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
17. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
[TBL] [Abstract][Full Text] [Related]
18. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.
Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382
[TBL] [Abstract][Full Text] [Related]
19. Priming of CD8 T cells by adenoviral vectors is critically dependent on B7 and dendritic cells but only partially dependent on CD28 ligation on CD8 T cells.
Nielsen KN; Steffensen MA; Christensen JP; Thomsen AR
J Immunol; 2014 Aug; 193(3):1223-32. PubMed ID: 24951814
[TBL] [Abstract][Full Text] [Related]
20. Chimpanzee-origin adenovirus vectors as vaccine carriers.
Tatsis N; Tesema L; Robinson ER; Giles-Davis W; McCoy K; Gao GP; Wilson JM; Ertl HC
Gene Ther; 2006 Mar; 13(5):421-9. PubMed ID: 16319951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
